Ohmine Takahiro, Iwasa Kazuomi, Yamaoka Terutoshi
Department of Vascular Surgery, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan.
Ann Vasc Dis. 2015;8(4):275-81. doi: 10.3400/avd.oa.15-00076. Epub 2015 Sep 11.
In patients with peripheral arterial diseases (PADs) due to infra-popliteal (below the knee; BTK) lesions, we often encounter situations requiring the immediate selection of either of two revascularization methods, namely bypass surgery or endovascular therapy (EVT). However, the question of whether endovascular or surgical revascularization should be performed initially for critical limb ischemia (CLI) patients with BTK lesions has not been clarified. To assess the efficacy and durability of EVT or bypass as a first approach, we evaluated the short- and mid-term outcomes of the first revascularizations achieved using EVT (EVT First Group; EVT-first) compared with bypass (Bypass First Group; Bypass-first). To verify the validity of each initial revascularization, we explored factors influencing overall survival (OS) rates using multivariate analyses.
A total of 169 consecutive BTK revascularization procedures (150 patients) for CLI conducted at our facility between November 2006 and July 2012 were analyzed. Patients undergoing revascularization were divided into two groups (EVT-first or Bypass-first), with 102 patients undergoing endovascular therapy first (EVT-first) and 51 undergoing bypass surgery first (Bypass-first). No statistically significant differences were noted between the two groups with respect to preoperative background including age, gender, and cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, coronary arterial disease (CAD), chronic heart failure (CHF), cerebrovascular disease, and hemodialysis). Technical success was defined as a single straight-line flow to the ankle after completion angiography of the first revascularization method. Hemodynamic success was defined as a postoperative skin perfusion pressure of the foot exceeding 40 mmHg.
The average age of patients was 76.0 years (range, 46-98 years; 65 men and 37 women) and 72.3 years (range, 43-93 years; 35 men and 13 women) in the EVT-first and Bypass-first groups, respectively. Patient follow-up ranged from 1 to 50 months (mean, 15 months). Respective technical and hemodynamic success rates were 96.2% and 66.7% for EVT-first and 100% and 94% for Bypass-first, respectively. Treatment was required an average of 1.5 times for EVT-first and 1.2 times for Bypass-first. Respective rates for other factors examined in the EVT-first and the Bypass-first groups were: major amputation rates 30 days post-procedure, 5.9%, and 3.9%; mortality rates 30 days post-procedure, 3.9%, and 0%; one-year AFS rates, 71.7%, and 79.5%; OS rates, 73.5% and 83.9%; and limb salvage rates, 88.8%, and 91.0%. Multivariate-analysis of all subjects in the two groups revealed that the OS rates were affected by four risk factors as follows: (1) age greater than 80 years, (2) CAD, (3) CHF, and (4) a non-ambulatory limb.
For patients with CLI due to BTK lesions and whose saphenous veins are in poor condition or are in poor general condition having two or more of the four severe risk factors, the EVT-First procedure is effective and provides durable results. Overall survival in patients with CLI due to BTK lesions is worse when patients have more than two severe risk factors, which is non-ambulatory limb, aged less than 81 years, with CAD or with CHF. (This article is a translation of Jpn J Vasc Surg 2014; 23: 766-773.).
在因腘动脉以下(膝下;BTK)病变导致外周动脉疾病(PAD)的患者中,我们经常遇到需要立即选择两种血管重建方法之一的情况,即旁路手术或血管内治疗(EVT)。然而,对于患有BTK病变的严重肢体缺血(CLI)患者,应首先进行血管内还是外科血管重建的问题尚未明确。为了评估EVT或旁路作为首选方法的疗效和持久性,我们评估了与旁路(旁路优先组;旁路优先)相比,使用EVT(EVT优先组;EVT优先)实现的首次血管重建的短期和中期结果。为了验证每次初始血管重建的有效性,我们使用多变量分析探索了影响总生存率(OS)的因素。
对2006年11月至2012年7月在我们机构进行的169例连续的CLI的BTK血管重建手术(150例患者)进行了分析。接受血管重建的患者分为两组(EVT优先或旁路优先),102例患者首先接受血管内治疗(EVT优先),51例患者首先接受旁路手术(旁路优先)。两组在术前背景(包括年龄、性别和心血管危险因素(高血压、糖尿病、高脂血症、冠状动脉疾病(CAD)、慢性心力衰竭(CHF)、脑血管疾病和血液透析))方面没有统计学上的显著差异。技术成功定义为首次血管重建方法完成血管造影后至踝关节的单一直线血流。血流动力学成功定义为术后足部皮肤灌注压超过40 mmHg。
EVT优先组和旁路优先组患者的平均年龄分别为76.0岁(范围46 - 98岁;65名男性和37名女性)和72.3岁(范围43 - 93岁;35名男性和13名女性)。患者随访时间为1至50个月(平均15个月)。EVT优先组的技术成功率和血流动力学成功率分别为96.2%和66.7%,旁路优先组分别为100%和94%。EVT优先组平均需要治疗1.5次,旁路优先组平均需要治疗1.2次。EVT优先组和旁路优先组中其他检查因素的各自发生率如下:术后30天的大截肢率分别为5.9%和3.9%;术后30天的死亡率分别为3.9%和0%;一年的AFS率分别为71.7%和79.5%;OS率分别为73.5%和83.9%;肢体挽救率分别为88.8%和91.0%。对两组所有受试者的多变量分析显示,OS率受以下四个危险因素影响:(1)年龄大于80岁,(2)CAD,(3)CHF,(4)非行走肢体。
对于因BTK病变导致CLI且大隐静脉状况不佳或总体状况不佳且有四个严重危险因素中的两个或更多的患者,EVT优先手术是有效的且能提供持久的结果。当患有BTK病变的CLI患者有两个以上严重危险因素,即非行走肢体、年龄小于81岁、患有CAD或患有CHF时,其总体生存率较差。(本文是对《日本血管外科学杂志》2014年;23: 766 - 773的翻译。)